메뉴 건너뛰기
Antimicrobial Agents and Chemotherapy
Volumn 60, Issue 3, 2016, Pages 1717-1724
Combination effects of antimicrobial peptides
Author keywords

[No Author keywords available]
Indexed keywords

AMPICILLIN; CECROPIN A; CIPROFLOXACIN; GENTAMICIN; INDOLICIDIN; KANAMYCIN; LL 19 27; MAGAININ 2; MELITTIN; NEOMYCIN; PEXIGANAN; POLYPEPTIDE ANTIBIOTIC AGENT; RIFABUTIN; SPECTINOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;
EID: 84960156612     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02434-15     Document Type: Article
Times cited : (174)
References (60)
  • 1
    • 0029036955 scopus 로고
    • The search for synergy: A critical review from a response surface perspective
    • Greco WR, Bravo G, Parsons JC. 1995. The search for synergy: A critical review from a response surface perspective. Pharmacol Rev 47:331-385.
    • (1995) Pharmacol Rev , vol.47 , pp. 331-385
    • Greco, W.R.1    Bravo, G.2    Parsons, J.C.3
  • 2
    • 33748794547 scopus 로고    scopus 로고
    • Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
    • Chou TC. 2006. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621-681. http://dx.doi.org/10.1124/pr.58.3.10.
    • (2006) Pharmacol Rev , vol.58 , pp. 621-681
    • Chou, T.C.1
  • 3
    • 84884680278 scopus 로고    scopus 로고
    • Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development
    • Imamovic L, Sommer MO. 2013. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med 5:204ra132. http://dx.doi.org/10.1126/scitranslmed.3006609.
    • (2013) Sci Transl Med , vol.5 , pp. 204-132
    • Imamovic, L.1    Sommer, M.O.2
  • 5
    • 84863654489 scopus 로고    scopus 로고
    • Combination therapy for treatment of infections with gram-negative bacteria
    • Tamma PD, Cosgrove SE, Maragakis LL. 2012. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 25:450-470. http://dx.doi.org/10.1128/CMR.05041-11.
    • (2012) Clin Microbiol Rev , vol.25 , pp. 450-470
    • Tamma, P.D.1    Cosgrove, S.E.2    Maragakis, L.L.3
  • 6
    • 84875261410 scopus 로고    scopus 로고
    • Combination approaches to combat multidrug-resistant bacteria
    • Worthington RJ, Melander C. 2013. Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol 31:177-184. http://dx .doi.org/10.1016/j.tibtech.2012.12.006.
    • (2013) Trends Biotechnol , vol.31 , pp. 177-184
    • Worthington, R.J.1    Melander, C.2
  • 7
    • 84876955225 scopus 로고    scopus 로고
    • When the most potent combination of antibiotics selects for the greatest bacterial load: The smilefrown transition
    • Pena-Miller R, Laehnemann D, Jansen G, Fuentes-Hernandez A, Rosenstiel P, Schulenburg H, Beardmore R. 2013. When the most potent combination of antibiotics selects for the greatest bacterial load: The smilefrown transition. PLoS Biol 11:e1001540. http://dx.doi.org/10.1371/journal.pbio.1001540.
    • (2013) PLoS Biol , vol.11 , pp. e1001540
    • Pena-Miller, R.1    Laehnemann, D.2    Jansen, G.3    Fuentes-Hernandez, A.4    Rosenstiel, P.5    Schulenburg, H.6    Beardmore, R.7
  • 8
    • 65649124513 scopus 로고    scopus 로고
    • Drug interactions and the evolution of antibiotic resistance
    • Yeh PJ, Hegreness MJ, Aiden AP, Kishony R. 2009. Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol 7:460-466. http://dx.doi.org/10.1038/nrmicro2133.
    • (2009) Nat Rev Microbiol , vol.7 , pp. 460-466
    • Yeh, P.J.1    Hegreness, M.J.2    Aiden, A.P.3    Kishony, R.4
  • 9
    • 34247277741 scopus 로고    scopus 로고
    • Antibiotic interactions that select against resistance
    • Chait R, Craney A, Kishony R. 2007. Antibiotic interactions that select against resistance. Nature 446:668-671. http://dx.doi.org/10.1038/nature05685.
    • (2007) Nature , vol.446 , pp. 668-671
    • Chait, R.1    Craney, A.2    Kishony, R.3
  • 10
    • 0001663843 scopus 로고
    • The problem of synergism and antagonism of combined drugs
    • Loewe S. 1953. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3:285-290.
    • (1953) Arzneimittelforschung , vol.3 , pp. 285-290
    • Loewe, S.1
  • 11
    • 84876847093 scopus 로고    scopus 로고
    • The pharmaco-, population and evolutionary dynamics of multi-drug therapy: Experiments with S. Aureus and E. Coli and computer simulations
    • Ankomah P, Johnson PJ, Levin BR. 2013. The pharmaco-, population and evolutionary dynamics of multi-drug therapy: Experiments with S. aureus and E. coli and computer simulations. PLoS Pathog 9:e1003300. http://dx.doi.org/10.1371/journal.ppat.1003300.
    • (2013) PLoS Pathog , vol.9 , pp. e1003300
    • Ankomah, P.1    Johnson, P.J.2    Levin, B.R.3
  • 13
    • 54449092082 scopus 로고    scopus 로고
    • Drug interactions modulate the potential for evolution of resistance
    • Michel JB, Yeh PJ, Chait R, Moellering RC, Jr, Kishony R. 2008. Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci U S A 105:14918-14923. http://dx.doi.org/10.1073/pnas.0800944105.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 14918-14923
    • Michel, J.B.1    Yeh, P.J.2    Chait, R.3    Moellering, R.C.4    Kishony, R.5
  • 14
    • 84864369297 scopus 로고    scopus 로고
    • Mechanismindependent method for predicting response to multidrug combinations in bacteria
    • Wood K, Nishida S, Sontag ED, Cluzel P. 2012. Mechanismindependent method for predicting response to multidrug combinations in bacteria. Proc Natl Acad Sci U S A 109:12254-12259. http://dx.doi.org/10.1073/pnas.1201281109.
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 12254-12259
    • Wood, K.1    Nishida, S.2    Sontag, E.D.3    Cluzel, P.4
  • 15
    • 84901650565 scopus 로고    scopus 로고
    • Linear superposition and prediction of bacterial promoter activity dynamics in complex conditions
    • Rothschild D, Dekel E, Hausser J, Bren A, Aidelberg G, Szekely P, Alon U. 2014. Linear superposition and prediction of bacterial promoter activity dynamics in complex conditions. PLoS Comput Biol 10:e1003602. http://dx.doi.org/10.1371/journal.pcbi.1003602.
    • (2014) PLoS Comput Biol , vol.10 , pp. e1003602
    • Rothschild, D.1    Dekel, E.2    Hausser, J.3    Bren, A.4    Aidelberg, G.5    Szekely, P.6    Alon, U.7
  • 17
    • 0035032985 scopus 로고    scopus 로고
    • Synergistic interactions between mammalian antimicrobial defense peptides
    • Yan H, Hancock RE. 2001. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother 45:1558-1560. http://dx.doi.org/10.1128/AAC.45.5.1558-1560.2001.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 1558-1560
    • Yan, H.1    Hancock, R.E.2
  • 18
    • 84878494094 scopus 로고    scopus 로고
    • Immune-and wound-dependent differential gene expression in an ancient insect
    • Johnston PR, Rolff J. 2013. Immune-and wound-dependent differential gene expression in an ancient insect. Dev Comp Immunol 40:320-324. http://dx.doi.org/10.1016/j.dci.2013.01.012.
    • (2013) Dev Comp Immunol , vol.40 , pp. 320-324
    • Johnston, P.R.1    Rolff, J.2
  • 19
    • 84902499130 scopus 로고    scopus 로고
    • Inducible defenses stay up late: Temporal patterns of immune gene expression in Tenebrio molitor
    • (Bethesda, Md.)
    • Johnston PR, Makarova O, Rolff J. 2014. Inducible defenses stay up late: Temporal patterns of immune gene expression in Tenebrio molitor. G3 (Bethesda, Md.) 4:947-955. http://dx.doi.org/10.1534/g3.113.008516.
    • (2014) G3 , vol.4 , pp. 947-955
    • Johnston, P.R.1    Makarova, O.2    Rolff, J.3
  • 20
    • 33947393032 scopus 로고    scopus 로고
    • Antimicrobial peptides: An overview of a promising class of therapeutics
    • Giuliani A, Pirri G, Nicoletto SF. 2007. Antimicrobial peptides: An overview of a promising class of therapeutics. Cent Eur J Biol 2:1-33.
    • (2007) Cent Eur J Biol , vol.2 , pp. 1-33
    • Giuliani, A.1    Pirri, G.2    Nicoletto, S.F.3
  • 21
    • 33645834508 scopus 로고    scopus 로고
    • Experimental evolution of resistance to an antimicrobial peptide
    • Perron GG, Zasloff M, Bell G. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci 273:251-256. http://dx.doi.org/10.1098/rspb.2005.3301.
    • (2006) Proc Biol Sci , vol.273 , pp. 251-256
    • Perron, G.G.1    Zasloff, M.2    Bell, G.3
  • 22
    • 84908344823 scopus 로고    scopus 로고
    • Antimicrobials, stress and mutagenesis
    • Rodriguez-Rojas A, Makarova O, Rolff J. 2014. Antimicrobials, stress and mutagenesis. PLoS Pathog 10:e1004445. http://dx.doi.org/10.1371/journal.ppat.1004445.
    • (2014) PLoS Pathog , vol.10 , pp. e1004445
    • Rodriguez-Rojas, A.1    Makarova, O.2    Rolff, J.3
  • 23
    • 84908068515 scopus 로고    scopus 로고
    • Increased survival of experimentally evolved antimicrobial peptide-resistant Staphylococcus aureus in an animal host
    • Dobson AJ, Purves J, Rolff J. 2014. Increased survival of experimentally evolved antimicrobial peptide-resistant Staphylococcus aureus in an animal host. Evol Appl 7:905-912. http://dx.doi.org/10.1111/eva.12184.
    • (2014) Evol Appl , vol.7 , pp. 905-912
    • Dobson, A.J.1    Purves, J.2    Rolff, J.3
  • 25
    • 84926374263 scopus 로고    scopus 로고
    • Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria
    • Poppel AK, Vogel H, Wiesner J, Vilcinskas A. 2015. Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria. Antimicrob Agents Chemother 59:2508-2514. http://dx.doi.org/10.1128/AAC.05180-14.
    • (2015) Antimicrob Agents Chemother , vol.59 , pp. 2508-2514
    • Poppel, A.K.1    Vogel, H.2    Wiesner, J.3    Vilcinskas, A.4
  • 26
    • 4644287346 scopus 로고    scopus 로고
    • Pharmacodynamic functions: A multiparameter approach to the design of antibiotic treatment regimens
    • Regoes RR, Wiuff C, Zappala RM, Garner KN, Baquero F, Levin BR. 2004. Pharmacodynamic functions: A multiparameter approach to the design of antibiotic treatment regimens. Antimicrob Agents Chemother 48: 3670-3676. http://dx.doi.org/10.1128/AAC.48.10.3670-3676.2004.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 3670-3676
    • Regoes, R.R.1    Wiuff, C.2    Zappala, R.M.3    Garner, K.N.4    Baquero, F.5    Levin, B.R.6
  • 27
    • 0023000770 scopus 로고
    • A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions
    • Zhi JG, Nightingale CH, Quintiliani R. 1986. A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions. J Pharm Sci 75:1063-1067. http://dx.doi.org/10.1002/jps.2600751108.
    • (1986) J Pharm Sci , vol.75 , pp. 1063-1067
    • Zhi, J.G.1    Nightingale, C.H.2    Quintiliani, R.3
  • 28
    • 0029967445 scopus 로고    scopus 로고
    • Pharmacokinetic pharmacodynamic modeling of the antibiotic effect of piperacillin in vitro
    • Nolting A, Dalla Costa T, Rand KH, Derendorf H. 1996. Pharmacokinetic pharmacodynamic modeling of the antibiotic effect of piperacillin in vitro. Pharm Res 13:91-96. http://dx.doi.org/10.1023/A:1016085402278.
    • (1996) Pharm Res , vol.13 , pp. 91-96
    • Nolting, A.1    Dalla Costa, T.2    Rand, K.H.3    Derendorf, H.4
  • 29
    • 0037165196 scopus 로고    scopus 로고
    • Antimicrobial peptides of multicellular organisms
    • Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395. http://dx.doi.org/10.1038/415389a.
    • (2002) Nature , vol.415 , pp. 389-395
    • Zasloff, M.1
  • 30
    • 23444437935 scopus 로고    scopus 로고
    • A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs
    • Gordon YJ, Romanowski EG, McDermott AM. 2005. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 30:505-515. http://dx.doi.org/10.1080/02713680590968637.
    • (2005) Curr Eye Res , vol.30 , pp. 505-515
    • Gordon, Y.J.1    Romanowski, E.G.2    McDermott, A.M.3
  • 31
    • 84899523048 scopus 로고    scopus 로고
    • Cationic membrane-active peptides- anticancer and antifungal activity as well as penetration into human skin
    • Do N, Weindl G, Grohmann L, Salwiczek M, Koksch B, Korting HC, Schafer-Korting M. 2014. Cationic membrane-active peptides- anticancer and antifungal activity as well as penetration into human skin. Exp Dermatol 23:326-331. http://dx.doi.org/10.1111/exd.12384.
    • (2014) Exp Dermatol , vol.23 , pp. 326-331
    • Do, N.1    Weindl, G.2    Grohmann, L.3    Salwiczek, M.4    Koksch, B.5    Korting, H.C.6    Schafer-Korting, M.7
  • 32
    • 0028504387 scopus 로고
    • Preliminary experimental anticancer activity of cecropins
    • Moore AJ, Devine DA, Bibby MC. 1994. Preliminary experimental anticancer activity of cecropins. Peptide Res 7:265-269.
    • (1994) Peptide Res , vol.7 , pp. 265-269
    • Moore, A.J.1    Devine, D.A.2    Bibby, M.C.3
  • 33
    • 77958581350 scopus 로고    scopus 로고
    • Serum stabilities of short tryptophan-and arginine-rich antimicrobial peptide analogs
    • Nguyen LT, Chau JK, Perry NA, De Boer L, Zaat SA, Vogel HJ. 2010. Serum stabilities of short tryptophan-and arginine-rich antimicrobial peptide analogs. PLoS One 5:e12684. http://dx.doi.org/10.1371/journal .pone.0012684.
    • (2010) PLoS One , vol.5 , pp. e12684
    • Nguyen, L.T.1    Chau, J.K.2    Perry, N.A.3    De Boer, L.4    Zaat, S.A.5    Vogel, H.J.6
  • 34
    • 77952544839 scopus 로고    scopus 로고
    • Structurefunction studies of chemokine-derived carboxy-terminal antimicrobial peptides
    • Nguyen LT, Chan DI, Boszhard L, Zaat SA, Vogel HJ. 2010. Structurefunction studies of chemokine-derived carboxy-terminal antimicrobial peptides. Biochim Biophys Acta 1798:1062-1072. http://dx.doi.org/10.1016/j.bbamem.2009.11.021.
    • (2010) Biochim Biophys Acta , vol.1798 , pp. 1062-1072
    • Nguyen, L.T.1    Chan, D.I.2    Boszhard, L.3    Zaat, S.A.4    Vogel, H.J.5
  • 35
    • 39449086721 scopus 로고    scopus 로고
    • Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
    • Wiegand I, Hilpert K, Hancock RE. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3:163-175. http://dx.doi.org/10.1038/nprot.2007.521.
    • (2008) Nat Protoc , vol.3 , pp. 163-175
    • Wiegand, I.1    Hilpert, K.2    Hancock, R.E.3
  • 36
    • 79955637689 scopus 로고    scopus 로고
    • Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37
    • Sochacki KA, Barns KJ, Bucki R, Weisshaar JC. 2011. Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37. Proc Natl Acad Sci U S A 108:E77-E81. http://dx.doi.org/10.1073/pnas .1101130108.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , pp. 77-81
    • Sochacki, K.A.1    Barns, K.J.2    Bucki, R.3    Weisshaar, J.C.4
  • 37
    • 84884898860 scopus 로고    scopus 로고
    • Localized permeabilization of E. Coli membranes by the antimicrobial peptide cecropin A
    • Rangarajan N, Bakshi S, Weisshaar JC. 2013. Localized permeabilization of E. coli membranes by the antimicrobial peptide cecropin A. Biochemistry 52:6584-6594. http://dx.doi.org/10.1021/bi400785j.
    • (2013) Biochemistry , vol.52 , pp. 6584-6594
    • Rangarajan, N.1    Bakshi, S.2    Weisshaar, J.C.3
  • 39
    • 84914179053 scopus 로고    scopus 로고
    • R Foundation for Statistical Computing, Vienna, Austria
    • R Core Team. 2014. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.
    • (2014) R A Language and Environment for Statistical Computing
  • 40
    • 84857474188 scopus 로고    scopus 로고
    • Two-drug antimicrobial chemotherapy: A mathematical model and experiments with Mycobacterium marinum
    • Ankomah P, Levin BR. 2012. Two-drug antimicrobial chemotherapy: A mathematical model and experiments with Mycobacterium marinum. PLoS Pathog 8:e1002487. http://dx.doi.org/10.1371/journal.ppat.1002487.
    • (2012) PLoS Pathog , vol.8 , pp. e1002487
    • Ankomah, P.1    Levin, B.R.2
  • 42
    • 0035651528 scopus 로고    scopus 로고
    • Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis
    • Monzon M, Oteiza C, Leiva J, Amorena B. 2001. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 48:793-801. http://dx.doi.org/10.1093/jac/48.6.793.
    • (2001) J Antimicrob Chemother , vol.48 , pp. 793-801
    • Monzon, M.1    Oteiza, C.2    Leiva, J.3    Amorena, B.4
  • 43
    • 80054678276 scopus 로고    scopus 로고
    • Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteria
    • Chongsiriwatana NP, Wetzler M, Barron AE. 2011. Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteria. Antimicrob Agents Chemother 55:5399-5402. http://dx.doi.org/10.1128/AAC.00578-11.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 5399-5402
    • Chongsiriwatana, N.P.1    Wetzler, M.2    Barron, A.E.3
  • 44
    • 84858003063 scopus 로고    scopus 로고
    • Antibiotic and antimicrobial peptide combinations: Synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants
    • Naghmouchi K, Le Lay C, Baah J, Drider D. 2012. Antibiotic and antimicrobial peptide combinations: Synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Res Microbiol 163:101-108. http://dx.doi.org/10.1016/j.resmic.2011.11.002.
    • (2012) Res Microbiol , vol.163 , pp. 101-108
    • Naghmouchi, K.1    Le Lay, C.2    Baah, J.3    Drider, D.4
  • 45
    • 84865599210 scopus 로고    scopus 로고
    • Synergistic effect of antimicrobial peptide arenicin-1 in combination with antibiotics against pathogenic bacteria
    • Choi H, Lee DG. 2012. Synergistic effect of antimicrobial peptide arenicin-1 in combination with antibiotics against pathogenic bacteria. Res Microbiol 163:479-486. http://dx.doi.org/10.1016/j.resmic.2012.06.001.
    • (2012) Res Microbiol , vol.163 , pp. 479-486
    • Choi, H.1    Lee, D.G.2
  • 47
    • 14544282377 scopus 로고    scopus 로고
    • Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?
    • Brogden KA. 2005. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-250. http://dx.doi.org/10.1038/nrmicro1098.
    • (2005) Nat Rev Microbiol , vol.3 , pp. 238-250
    • Brogden, K.A.1
  • 48
    • 84902536156 scopus 로고    scopus 로고
    • Microbiological effects of sublethal levels of antibiotics
    • Andersson DI, Hughes D. 2014. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 12:465-478. http://dx.doi.org/10.1038/nrmicro3270.
    • (2014) Nat Rev Microbiol , vol.12 , pp. 465-478
    • Andersson, D.I.1    Hughes, D.2
  • 49
    • 84936986192 scopus 로고    scopus 로고
    • Is selection relevant in the evolutionary emergence of drug resistance?
    • Day T, Huijben S, Read AF. 2015. Is selection relevant in the evolutionary emergence of drug resistance? Trends Microbiol 23:126-133. http://dx .doi.org/10.1016/j.tim.2015.01.005.
    • (2015) Trends Microbiol , vol.23 , pp. 126-133
    • Day, T.1    Huijben, S.2    Read, A.F.3
  • 50
    • 0038639673 scopus 로고    scopus 로고
    • The mutant selection window and antimicrobial resistance
    • Drlica K. 2003. The mutant selection window and antimicrobial resistance. J Antimicrob Chemother 52:11-17. http://dx.doi.org/10.1093/jac/dkg269.
    • (2003) J Antimicrob Chemother , vol.52 , pp. 11-17
    • Drlica, K.1
  • 51
    • 33847045214 scopus 로고    scopus 로고
    • Mutant selection window hypothesis updated
    • Drlica K, Zhao X. 2007. Mutant selection window hypothesis updated. Clin Infect Dis 44:681-688. http://dx.doi.org/10.1086/511642.
    • (2007) Clin Infect Dis , vol.44 , pp. 681-688
    • Drlica, K.1    Zhao, X.2
  • 52
    • 84883277648 scopus 로고    scopus 로고
    • Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi
    • Berghaus LJ, Giguere S, Guldbech K. 2013. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi. Vet Microbiol 166:670-675. http://dx.doi.org/10.1016/j.vetmic.2013.07.006.
    • (2013) Vet Microbiol , vol.166 , pp. 670-675
    • Berghaus, L.J.1    Giguere, S.2    Guldbech, K.3
  • 53
    • 58649103313 scopus 로고    scopus 로고
    • Exploring the role of the immune response in preventing antibiotic resistance
    • Handel A, Margolis E, Levin BR. 2009. Exploring the role of the immune response in preventing antibiotic resistance. J Theor Biol 256:655-662. http://dx.doi.org/10.1016/j.jtbi.2008.10.025.
    • (2009) J Theor Biol , vol.256 , pp. 655-662
    • Handel, A.1    Margolis, E.2    Levin, B.R.3
  • 54
    • 84885723371 scopus 로고    scopus 로고
    • Comparing selection on S. Aureus between antimicrobial peptides and common antibiotics
    • Dobson AJ, Purves J, Kamysz W, Rolff J. 2013. Comparing selection on S. aureus between antimicrobial peptides and common antibiotics. PLoS One 8:e76521. http://dx.doi.org/10.1371/journal.pone.0076521.
    • (2013) PLoS One , vol.8 , pp. e76521
    • Dobson, A.J.1    Purves, J.2    Kamysz, W.3    Rolff, J.4
  • 55
    • 56749158645 scopus 로고    scopus 로고
    • Antimicrobial defense and persistent infection in insects
    • Haine ER, Moret Y, Siva-Jothy MT, Rolff J. 2008. Antimicrobial defense and persistent infection in insects. Science 322:1257-1259. http://dx.doi .org/10.1126/science.1165265.
    • (2008) Science , vol.322 , pp. 1257-1259
    • Haine, E.R.1    Moret, Y.2    Siva-Jothy, M.T.3    Rolff, J.4
  • 56
    • 0025374728 scopus 로고
    • Peptides from frog skin
    • Bevins CL, Zasloff M. 1990. Peptides from frog skin. Annu Rev Biochem 59:395-414. http://dx.doi.org/10.1146/annurev.bi.59.070190.002143.
    • (1990) Annu Rev Biochem , vol.59 , pp. 395-414
    • Bevins, C.L.1    Zasloff, M.2
  • 57
    • 77949569493 scopus 로고    scopus 로고
    • Antibiotic resistance and its cost: Is it possible to reverse resistance?
    • Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat Rev Microbiol 8:260-271. http://dx.doi .org/10.1038/nrmicro2319.
    • (2010) Nat Rev Microbiol , vol.8 , pp. 260-271
    • Andersson, D.I.1    Hughes, D.2
  • 58
    • 33748693294 scopus 로고    scopus 로고
    • The biological cost of mutational antibiotic resistance: Any practical conclusions?
    • Andersson DI. 2006. The biological cost of mutational antibiotic resistance: Any practical conclusions? Curr Opin Microbiol 9:461-465. http://dx.doi.org/10.1016/j.mib.2006.07.002.
    • (2006) Curr Opin Microbiol , vol.9 , pp. 461-465
    • Andersson, D.I.1
  • 59
    • 84925306196 scopus 로고    scopus 로고
    • Costs of antibiotic resistance-separating trait effects and selective effects
    • Hall AR, Angst DC, Schiessl KT, Ackermann M. 2015. Costs of antibiotic resistance-separating trait effects and selective effects. Evol Appl 8:261-272. http://dx.doi.org/10.1111/eva.12187.
    • (2015) Evol Appl , vol.8 , pp. 261-272
    • Hall, A.R.1    Angst, D.C.2    Schiessl, K.T.3    Ackermann, M.4
  • 60
    • 84925296085 scopus 로고    scopus 로고
    • The genetic basis of the fitness costs of antimicrobial resistance: A meta-analysis approach
    • Vogwill T, MacLean RC. 2015. The genetic basis of the fitness costs of antimicrobial resistance: A meta-analysis approach. Evol Appl 8:284-295. http://dx.doi.org/10.1111/eva.12202.
    • (2015) Evol Appl , vol.8 , pp. 284-295
    • Vogwill, T.1    MacLean, R.C.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.